Details of the Drug Reposition

General Information of This Drug (ID: DMWUQI9)

Drug Name	CER-001 DMWUQI9

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Cardiovascular disease	DIS2IQDX	BA00-BE2Z	Phase 2	[1]
Acute coronary syndrome	DIS7DYEW	BA41	Phase 2	[2]
------------------------------------------------------------------------------------

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2	ClinicalTrials.gov (NCT01412034) Effect of CER-001 on Plaque Volume in Homozygous Familial Hypercholesterolemia (HoFH) Subjects. U.S. National Institutes of Health.